August 18, 2022 1:45 p.m. EDT
(24/7 MARKET NEWS) –Mind Medicine (NASDAQ: MNMD) caught our attention in this morning’s premarket.
After opening at $1.19 and running to a high of $1.33, the clinical stage biopharmaceutical company, which is developing novel products to treat brain health disorders, drifted down to a low of $0.9023. It’s bounced off of the low and may take another shot at its high-of-the-day. It’s now trading at $1.09, up $0.341 (+45.53%), on over 163 million shares.
The move is being powered by reports that Jake Freeman, a USC student who, according to Securities and Exchange Commission filings, booked $110 million in profits from recent meme-stock favorite, Bed Bath & Beyond, recently built up an activist stake in Mind Medicine.
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.